---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005899"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2026-08-03T12:52:10+00:00"
generated_at: "2026-08-03T12:55:08.649098+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma reduces Series B warrant exercise price to $1.2202 after ATM sales

## Summary
- Exercise price of Series B warrants reduced to $1.2202 due to recent common stock sales under ATM offering.
- Adjustment triggered by anti-dilution provisions in the warrant terms.
- Further adjustments may occur as set forth in the Series B warrant agreement.

## SEC filing metadata
- accession: 0001683168-26-005899
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2026-08-03T12:52:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/0001683168-26-005899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316826005899/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005899
- JSON: https://secwatch.observer/filing/0001683168-26-005899.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005899.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.